BACKGROUND Asthma has been associated with eosinophil activation, measured in serum, sputum, bronchoalveolar lavage (BAL) fluid, and urine. A whole blood automated method was developed to assess ...

Dividing the cohort based on blood eosinophil count revealed a larger drop in exacerbation rate with tezepelumab, with decreases of 37% (rate ratio = 0.63; 95% CI, 0.43-0.93) in the 150 cells/ μ ...

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months.

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.

Eosinophil-mediated endomyocardial damage is a well-known complication in patients with hypereosinophilic syndromes (HES). Although management and survival have improved significantly, some patients ...

This is a summary of the recommendations of the joint guideline on Asthma: diagnosis, monitoring and chronic asthma management, which was published in November 2024. This new collaborative guideline ...

Find allergy and asthma news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.

Pityrosporum folliculitis, also known as Malassezia folliculitis, is a common yeast infection of the hair follicles. 1 This condition is caused by Malassezia, a genus of lipophilic fungi that is part ...